These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6156529)

  • 41. Modification of kidney graft survival in dog and man by pre-operative transfusion to the donor.
    Jeekel J; Van der Linden CJ; Vegt PA; Buurman WA; Harder F; Persijn G
    Proc Eur Dial Transplant Assoc; 1980; 17():457-61. PubMed ID: 7017690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of high doses of intravenous methylprednisolone and cyclophosphamide on renal homografts.
    Zincke H; Woods JE; Holley KE
    Urology; 1977 Oct; 10(4):301-4. PubMed ID: 335605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunosuppression in canine renal allografts using niridazole.
    Sokucu N; Caridis DT; Moran J
    Transplantation; 1980 Apr; 29(4):306-7. PubMed ID: 6989050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved survival after donor pretreatment with anti-lymphoblast globulin (ALG) in perfused kidneys: experimental findings.
    Toledo-Pereyra LH; Taiyebb S; McKenzie GH; Gordon DA; Sy GS
    J Surg Res; 1981 Aug; 31(2):172-7. PubMed ID: 7022024
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of rapamycin on renal allograft survival in canine recipients treated with antilymphocyte serum, donor bone marrow, and cyclosporine.
    Hartner WC; Van der Werf WJ; Lodge JP; Gilchrist B; De Fazio SR; Markees TG; Yatko C; Monaco AP; Gozzo JJ
    Transplantation; 1995 Dec; 60(11):1347-50. PubMed ID: 8525533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study on the mechanism of donor pretreatment: effect of procarbazine hydrochloride and methylprednisolone in immunocompetent cells.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1981 Jul; 32(1):24-8. PubMed ID: 7022795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolongation of canine renal allograft survival by a new potent immunosuppressive agent, bactobolamine.
    Kikuchi K; Tomikawa S; Ito S; Ichikawa N; Ando Y; Meigata K; Nomura Y; Watanabe K; Beck Y; Degawa H; Nagao T; Uchida H
    Transplant Proc; 1996 Jun; 28(3):1392-3. PubMed ID: 8658709
    [No Abstract]   [Full Text] [Related]  

  • 48. Preoperative immunosuppression with antithymocyte serum and procarbazine: effect on kidney graft survival in dogs after donor or third-party antigen administration.
    van der Linden CJ; Harder F; Buurman WA; Fabricant AS; Greep JM; Jeekel J
    Transplant Proc; 1980 Jun; 12(2):352-4. PubMed ID: 6994306
    [No Abstract]   [Full Text] [Related]  

  • 49. In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection.
    Yen CY; Lin CY
    J Surg Res; 1996 May; 62(2):260-6. PubMed ID: 8632649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transplantation of islet cells.
    Toledo-Pereyra LH; Gordon DA; MacKenzie GH
    Surg Gynecol Obstet; 1984 Jan; 158(1):49-56. PubMed ID: 6419360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Graft pretreatment with cyclosporin A. Long-term study including four trials in one and a half years.
    Toledo-Pereyra LH; MacKenzie GH; Gordon DA; Walters J; Toben HR
    Am Surg; 1983 May; 49(5):261-70. PubMed ID: 6342488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
    Anderson CB; Sicard GA; Etheredge EE
    Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of donor age on renal allograft function and survival.
    Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
    Transplant Proc; 2009 Apr; 41(3):794-6. PubMed ID: 19376354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attempted immunological alteration of canine renal allograft donors.
    Zincke H; Woods JE
    Transplantation; 1974 Dec; 18(6):480-6. PubMed ID: 4612885
    [No Abstract]   [Full Text] [Related]  

  • 55. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Depletion of donor kidney dendritic cells prolongs graft survival.
    McKenzie JL; Beard ME; Hart DN
    Transplant Proc; 1984 Aug; 16(4):948-51. PubMed ID: 6380059
    [No Abstract]   [Full Text] [Related]  

  • 57. Attempted antigenic alteration of canine kidneys by 24- or 48-hr perfusion with immunosuppressive agents.
    Woods JE; Cooperman AM; Holley KE
    Transplantation; 1972 Mar; 13(3):336. PubMed ID: 4553735
    [No Abstract]   [Full Text] [Related]  

  • 58. Multifactorial analysis of factors influencing graft survival in recipients of living related renal allografts.
    Green WF; Niblack GD; Johnson HK; Richie RE; Tallent MB; MacDonnell R; Turner B; Harbison P; Ganaway S
    Transplant Proc; 1982 Jun; 14(2):282-6. PubMed ID: 6214057
    [No Abstract]   [Full Text] [Related]  

  • 59. Opiate receptor blockade improves function and survival of high-risk renal allografts.
    Nghiem DD
    Transplant Proc; 1993 Dec; 25(6):3195. PubMed ID: 8266512
    [No Abstract]   [Full Text] [Related]  

  • 60. Transplantation of kidneys from living related donors. Comparison with cadaveric kidney transplantation.
    Thomson NM; Atkins RC; Scott DF; Marshall VC; McGinley E; Holdsworth SR; Ironside W
    Med J Aust; 1983 Dec 10-24; 2(12):609-12. PubMed ID: 6366497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.